Prognostic significance of cardiac magnetic resonance imaging: Update 2010

Cardiology Journal

Volumn 17, Issue 6, 2010, Pages 549-557

  Hombach, Vinzenz ^a   Merkle, Nico ^a   Bernhard, Peter ^a   Rasche, Volker ^a   Rottbauer, Wolfgang ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Cardiac magnetic resonance imaging; Cardiac resynchronization therapy; Chronic heart failure; Coronary artery disease; Dilated cardiomyopathy; Hypertrophic cardiomyopathy; Late gadolinium enhancement; Prognosis

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST;

ACUTE HEART INFARCTION; ARTICLE; CARDIOVASCULAR DISEASE; CONGESTIVE CARDIOMYOPATHY; CONTRAST ENHANCEMENT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DEFIBRILLATOR; DIAGNOSTIC VALUE; GOLD STANDARD; HEART FAILURE; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE REMODELING; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; ISCHEMIC HEART DISEASE; MICROANGIOPATHY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS CORONARY INTERVENTION; PHARMACOLOGIC STRESS TESTING; PREDICTION; PREOPERATIVE EVALUATION; PROGNOSIS; RISK ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SUDDEN DEATH; TRANSTHORACIC ECHOCARDIOGRAPHY;

CONTRAST MEDIA; CORONARY CIRCULATION; HEART DISEASES; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX; VENTRICULAR FUNCTION, LEFT; VENTRICULAR FUNCTION, RIGHT;

EID: 78951475697     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Nagel E, Lehmkuhl HB, Boksch W et al. Non-invasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: Comparison with dobutamine stress echocardiography. Circulation, 1999; 99: 763-770.
2. Merkle N, Wöhrle J, Grebe O et al. Assessment of myocardial perfusion for detection of coronary artery stenoses by steadystate- free-precession magnetic resonance first-pass imaging. Heart, 2007; 93: 1381-1385.
3. Nandalur KR, Dwamena BA, Choudhri AF, Nandalus MR, Carlos RC. Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease. J Am Coll Cardiol, 2007; 50: 1343-1353.
4. Rerkpattanapipat P, Morgan TM, Neagle VM et al. Assessment of preoperative cardiac risk with magnetic resonance imaging. Am J Cardiol, 2002; 90: 416-519.
5. Jahnke C, Nagel E, Gebker R et al. Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation, 2007; 115: 1769-1776.
6. Hundley WG, Hamilton CA, Thomas MS et al. Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation, 1999; 100: 1697-1702.
7. Pilz G, Jeske A, Klos M et al. Prognostic value of normal adenosine- stress cardiac magnetic resonance imaging. Am J Cardiol, 2008; 101: 1408-1412.
8. Bodi V, Sanchis J, Lopez-Lereu MP et al. Prognostic value of dipyridamole stress cardiovascular magnetic resonance imaging in patients with known or suspected coronary artery disease. J Am Coll Cardiol, 2007; 50: 1174-1179.
9. Ingkanisorn WP, Kwong RY, Bohme NS et al. Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain. J Am Coll Cardiol, 2006; 47: 1427-1432.
10. Barbier CE, Bjerner T, Johansson L, Lind L, Ahlström H. Myocardial scars more frequent than expected: magnetic resonance imaging detects potential risk group. J Am Coll Cardiol, 2006; 48: 765-771.
11. Kwong RY, Chan AK, Brown KA et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation, 2006; 113: 2733-2743.
12. Kwong RY, Sattar H, Wu H et al. Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction. Circulation, 2008; 118: 1011-1020.
13. Schmidt A, Azevedo CF, Cheng A et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation, 2007; 115: 2006-2014.
14. Yan AT, Shayne AJ, Brown KA et al. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation, 2006; 114: 32-39.
15. Roes SD, Borleffs CJW, van der Geest RJ et al. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator. Circ Cardiovascular Imag, 2009; 2: 183-190.
16. Heidary S, Patel H, Chung J et al. Quantitative tissue characterization of infarct core and border zone in patients with ischemic cardiomyopathy by magnetic resonance is associated with future cardiovascular events. J Am Coll Cardiol, 2010; 55: 2762-2768.
17. Yokota H, Heidary S, Katikireddy CK et al. Quantitative characterization of myocardial infarction by cardiovascular magnetic resonance predicts future cardiovascular events in patients with ischemic cardiomyopathy. J Cardiovasc Magn Reson, 2008; 17: DOI:10.1186/1532-429X-10-17.
18. Cheong BYC, Muthupillai R, Wilson JM et al. Prognostic significance of delayed-enhancement magnetic resonance imaging survival of 857 patients with and without left ventricular dysfunction. Circulation, 2009; 120: 2069-2076.
19. Larose E, Rodes-Cabau J, Pibarot P et al. Predicting late myocardial recovery and outcomes in the early hours of ST-segment elevation myocardial infarction traditional measures compared with microvascular obstruction, salvaged myocardium, and necrosis characteristics by cardiovascular magnetic resonance. J Am Coll Cardiol, 2010; 55: 2459-2469.
20. Wu E, Ortiz JT, Tejedor P et al. Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: Prospective cohort study. Heart, 2008; 94: 730-736.
21. Plein S, Younger JF, Sparrow P et al. Cardiovascular magnetic resonance of scar and ischemia burden early after acute ST elevation and non-ST elevation myocardial infarction. J Cardiovasc Magn Reson, 2008; 10: 47.
22. Jensen CJ, Jochims M, Hunold P et al. Right ventricular involvement in acute left ventricular myocardial infarction: Prognostic implications of MRI findings. Am J Roentgenol, 2010; 194: 592-598.
23. Bueno H, Lopez-Palop R, Bermejo J, Lopez-Sendon JL, Delcan JL. In-hospital outcome of elderly patients with acute inferior myocardial infarction and right ventricular involvement. Circulation, 1997; 96: 436-441.
24. Giannitsis E, Hartmann F, Wiegand U, Katus HA, Richardt G. Clinical and angiographic outcome of patients with acute inferior myocardial infarction and right ventricular involvement treated with direct PTCA. Z Kardiol, 2000; 89: 28-35.
25. Hombach V, Grebe O, Merkle N et al. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J, 2005; 26: 549-557.
26. Kaandorp TAM, Lamb HJ, Poldermans D et al. Assessment of right ventricular infarction with contrast-enhanced magnetic resonance imaging. Coron Artery Dis, 2007; 18: 39-43.
27. Wu KC, Kim RJ, Bluemke DA et al. Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion. J Am Coll Cardiol, 1998; 32: 1756-1764.
28. Orn S, Manhenke C, Greve OJ et al. Microvascular obstruction is a major determinant of infarct healing and subsequent left ventricular remodelling following primary percutaneous coronary intervention. Eur Heart J, 2009; 30: 1978-1985.
29. Wu KC, Zerhouni EA, Judd RM et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation, 1998; 97: 765-772.
30. Nijveldt R, Beek AM, Hirsch A et al. Functional recovery after acute myocardial infarction. J Am Coll Cardiol, 2008; 52: 181-189.
31. Hirsch A, Nijveldt R, Haeck JDE et al. Relation between the assessment of microvascular injury by cardiovascular magnetic resonance and coronary Doppler flow velocity measurements in patients with acute anterior wall myocardial infarction. J Am Coll Cardiol, 2008; 51: 2230-2238.
32. Nijveldt R, Hofman MBM, Hirsch A et al. Assessment of microvascular obstruction and prediction of short-term remodeling after acute myocardial infarction: Cardiac MR imaging study. Radiology, 2009; 250: 363-370.
33. Bruder O, Breuckmann F, Jensen C et al. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network. Herz, 2008; 33: 136-142.
34. Kwon DH, Halley CM, Carrigan TP et al. Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: A delayed hyperenhancement cardiac magnetic resonance study. J Am Coll Cardiol Cardiovasc Imag, 2009; 2: 34-44.
35. Kim HW, Klem I, Shah DJ et al. Unrecognized non-Q-wave myocardial infarction: prevalence and prognostic significance in patients with suspected coronary disease. PLoS Med, 2009; 6: e1000057.
36. Nazarian S, Bluemke DA, Lardo AC et al. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation, 2005; 112: 2821-2825.
37. Yokokawa M, Tada H, Koyama K et al. The characteristics and distribution of the scar tissue predict ventricular tachycardia in patients with advanced heart failure. Pacing Clin Electrophysiol, 2009; 32: 314-322.
38. Assomull RG, Prasad SK, Lyne J et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol, 2006; 48: 1977-1985.
39. Wu KC, Weiss RG, Thiemann DR et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol, 2008; 51: 2414-2421.
40. Hombach V, Merkle N, Torzewski J et al. Electrocardiographic and cardiac magnetic resonance imaging parameters as predictors of a worse outcome in patients with idiopathic dilated cardiomyopathy. Eur Heart J, 2009; 30: 2011-2018.
41. Adabag AS, Maron BJ, Appelbaum E et al. Occurrence and frequency of arrythmias in hypertrophic cardiommyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol, 2008; 51: 1369-1374.
42. Suk T, Edwards C, Hart H, Christiansenn JP. Myocardial scar detected by contrast-enhanced cardiac magnetic resonance imaging is associated with ventricular tachycardia in hypertrophic cardiomyopathy patients. Heart Lung Circ, 2008; 17: 370-374.
43. Fluechter S, Kuschyk J, Wolpert C et al. Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson, 2010; 12: 30.
44. Leonardi S, Raineri C, De Ferrari GM et al. Usefulness of cardiac magnetic resonance in assessing the risk of ventricular arrhythmias and sudden death in patients with hypertrophic cardiomyopathy. Eur Heart J, 2009; 30: 2003-2010.
45. O'Hanlon R, Grasso A, Roughton M et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol, 2010; 56: 867-874.
46. Bruder O, Wagner A, Jensen CJ et al. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol, 2010; 56: 875-887.
47. Chalil S, Stegemann B, Muhyaldeen S et al. Intraventricular dyssynchrony predicts mortality and morbidity after cardiac resynchronization therapy: A study using cardiovascular magnetic resonance tissue synchronization imaging. J Am Coll Cardiol, 2007; 50: 243-252.
48. Leyva F, Foley PW, Stegemann B et al. Development and validation of a clinical index to predict survival after cardiac resynchronization therapy. Heart, 2009; 95: 1619-1625.